Key Players In The Bone & Joint Health Supplements Market

By Author: Sonal
Total Articles: 84
Comment this article

The global bone & joint health supplements market is estimated to be valued at USD 11.7 billion in 2022. It is projected to reach USD 17.6 billion by 2027, recording a CAGR of 8.5% during the forecast period.

Download PDF Brochure

Key players in this market include Bayer AG(Germany), Procter & Gamble (US), Amway (US), Basf SE (Germany), Archer Daniels Midland (US), Reckitt Benckiser (UK), Pfizer (US), Vita Life Sciences Ltd (Australia), Arazo Nutrition (US), Nature’s Sunshine Products, Inc (US), (France), and Glanbia Plc (Ireland).

Bayer is engaged in the manufacturing and distribution of products in the areas of healthcare and nutrition. The company operates through three major business segments- Crop science, pharmaceuticals, and consumer health. It offers bone and joint health supplements under its consumer health segment. It offers bone and joint health supplements through its brands Citracal which offers ...
... products in the form of caplets and gummies.

Procter and Gamble engages in the provision of consumer packaged goods. The company operates through five segments such as beauty, grooming, healthcare, fabric and home care, baby feminine and family care. The company manufactures bone and joint health supplements under its healthcare segment.

Make an Inquiry

Amway is one of the largest manufacturers of nutrition and personal care products. It offers its product through the nutrition, beauty, home, energy and sports segments. The company has brands such as Nutrilite, Artistry, Attitude, Satinique, and Dynamite. It offers bone and joint health products, such as vitamins and supplements, under the brand Nutrilite. Nutrition segment accounted for a share of 54% of the Amway’s market in 2019 whereas beauty & personal care were 25% in the same year.